Stock screenerAll disclosures →
EDGAR →
OSUR
Conviction 81HealthcareScan · Thu, Jun 25, 2026OSUR$4.41+1.50%
ResistanceSupportVol 14Insider buyVol MA14 717.1K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price4.41
Change+1.50%
Gap+0.46%
Rel volume1.07×
Avg volume781.5K
Avg $ vol3.28M
SMA 204.20
SMA 503.56
SMA 2003.00
Price vs 50+23.65%
Price vs 200+46.81%
MA stackbullish
50/200 cross—
Supertrendup · 3.73
RSI (14)64
MACD hist-0.02
MACD crossbear · 4d
Stoch %K / %D70 / 62
ADX (14)38
+DI / −DI25 / 11
RSI divergence—
MACD divergenceBearish
ATR %+4.85%
ADR %5.44%
52w high4.47
52w low2.11
From 52w high-1.45%
Above 52w low+108.77%
New 52w highNo
SqueezeOff
Bollinger width12.44%
%B0.90
Donchian pos74.64%
Donchian high4.58
Donchian low3.89
AVWAP (52w high)4.32
vs AVWAP high+1.91%
AVWAP (52w low)3.07
vs AVWAP low+43.53%
OBV trendFlat
Chaikin MF (20)0.04
Today vs 20d1.07×
Avg vol (14d)717.1K
Avg vol (20d)781.5K
Avg $ vol (20d)3.28M
Market cap303.28M
RS 3m (vs SPY)+29.57%
RS 6m (vs SPY)+73.85%
RS line new highNo
Trend template8/8
Technical rank92.9
1 week-1.45%
1 month+11.80%
3 months+40.29%
6 months+82.78%
1 year+46.83%
YTD+85.08%
P/E-4.41
P/B0.97
P/S2.64
P/FCF-5.70
EPS-0.9400
Div yield—
ROE-21.94%
ROA-18.13%
Debt/Eq0.02
Current5.46
EV/EBITDA-2.16
Gross margin41.90%
Net margin-59.76%
Rev growth-38.10%
EPS growth-252.47%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value133.36M
Revenue27.93M
Net income-22.38M
Gross profit11.8M
Free cash flow-53.22M
IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS
ExchangeNasdaq
Shares out68.85M
Employees500
ListedMon, Nov 17, 1986
Free float68.35M
Float %95.3%
Short interest2.84M
Days to cover3.5d
Short volume25.1%
Squeeze score27 / 100
Next earningsTue, Aug 4, 2026 (40d)
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeA
Conviction81 / 100
Pattern quality—
Tech rank92.9 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance4.46
Support2.92
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Signal lifecycle
How this symbol has moved through the lanes across 17 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.
- Broke outJun 11 scan
- Setting upJun 4 – Jun 155 scans
Congress activity
Disclosed STOCK Act trades in OSUR
No recent disclosed trades by Congress in OSUR. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in OSUR · 7 buys · 3 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Marmora Lelio Director · Common Stock · 2026-06-03 | Grant | 46.11K | $0 | 2026-06-03 | 2026-06-05 |
Boyd Steven Kyle Director · Common Stock · 2026-06-03 | Grant | 46.11K | $0 | 2026-06-03 | 2026-06-05 |
Bertrand John D. Director · Common Stock · 2026-06-03 | Grant | 46.11K | $0 | 2026-06-03 | 2026-06-05 |
Gagliano Nancy J Director · Common Stock · 2026-06-03 | Grant | 46.11K | $0 | 2026-06-03 | 2026-06-05 |
McMahon Robert W. Director · Common Stock · 2026-06-03 | Grant | 46.11K | $0 | 2026-06-03 | 2026-06-05 |
Kenny John P. Director · Common Stock · 2026-06-03 | Grant | 46.11K | $0 | 2026-06-03 | 2026-06-05 |
Boyd Steven Kyle Director · Common Stock · 2026-05-14 | Buy | 25K | $75K | 2026-05-14 | 2026-05-14 |
Marmora Lelio Director · Common Stock · 2026-05-13 | Tax | 28.41K | $86K | 2026-05-13 | 2026-05-14 |
McMahon Robert W. Director · Common Stock · 2026-05-13 | Tax | 22.89K | $69K | 2026-05-13 | 2026-05-14 |
Gagliano Nancy J Director · Common Stock · 2026-05-13 | Tax | 21.3K | $64K | 2026-05-13 | 2026-05-14 |
SEC filings
EDGAR filings in OSUR · 2 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.